- United Kingdom
- /
- Healthtech
- /
- AIM:FDBK
Feedback First Half 2023 Earnings: UK£0.10 loss per share (vs UK£0.20 loss in 1H 2022)
Feedback (LON:FDBK) First Half 2023 Results
Key Financial Results
- Revenue: UK£576.0k (up 222% from 1H 2022).
- Net loss: UK£1.37m (loss widened by 29% from 1H 2022).
- UK£0.10 loss per share.
All figures shown in the chart above are for the trailing 12 month (TTM) period
Feedback Earnings Insights
Looking ahead, revenue is forecast to grow 37% p.a. on average during the next 3 years, compared to a 16% growth forecast for the Healthcare Services industry in the United Kingdom.
Performance of the British Healthcare Services industry.
The company's shares are up 4.7% from a week ago.
Risk Analysis
We should say that we've discovered 3 warning signs for Feedback (1 is potentially serious!) that you should be aware of before investing here.
If you're looking to trade Feedback, open an account with the lowest-cost platform trusted by professionals, Interactive Brokers.
With clients in over 200 countries and territories, and access to 160 markets, IBKR lets you trade stocks, options, futures, forex, bonds and funds from a single integrated account.
Enjoy no hidden fees, no account minimums, and FX conversion rates as low as 0.03%, far better than what most brokers offer.
Sponsored ContentNew: AI Stock Screener & Alerts
Our new AI Stock Screener scans the market every day to uncover opportunities.
• Dividend Powerhouses (3%+ Yield)
• Undervalued Small Caps with Insider Buying
• High growth Tech and AI Companies
Or build your own from over 50 metrics.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About AIM:FDBK
Feedback
A medical imaging technology company, engages in the provision of software and systems to those working in the field of medical imaging.
Flawless balance sheet slight.
Market Insights
Community Narratives

